By using the Her2/neu-positive SKBR3 cells, we observed that the cytotoxic effect after reduction of the tumor cell-sialic acids was significantly higher, in comparison to treatment with the SIGLEC-5/14 alone (Figure 3c). The gene discussed is ERBB2; the disease is neoplasm.